Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Lung Cancer Surgery Market Through 2029?

The market size for lung cancer surgery has been on a steady rise in the past years. It’s projected to increase from $5.07 billion in 2024 to $5.33 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%. The historic growth has been fueled by factors such as high levels of smoking, an increase in lung cancer cases, development in hospital facilities, broadening insurance coverage, and an enhancement in the professional skills of surgeons.

In the coming years, consistent growth is anticipated in the lung cancer surgery market, with an estimated rise to $6.43 billion in 2029, reflecting a compound annual growth rate (CAGR) of 4.8%. This growth trajectory over the forecast period could be a result of several contributing factors, such as the aging global demographic, soaring cases of non-small cell lung cancer, increasing awareness in developing nations, a proliferation of robotic surgery platforms, as well as increased investment in cancer care. Noteworthy trends for the forecast period encompass robotic-assisted thoracic surgery, the implementation of augmented reality in surgical procedures, the application of 3-dimensional printing in surgical simulation, the use of artificial intelligence in surgical planning, along with the evolution of smart surgical instruments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

What Market Forces Are Driving The Lung Cancer Surgery Sector In 2025 And Beyond?

The rise in lung cancer cases is anticipated to boost the development of the lung cancer surgery market. Lung cancer, which is an unchecked proliferation of irregular cells in one or two lungs, disrupts normal lung function. This escalation in lung cancer cases is attributed to prolonged exposure to excellent particulate matter and air pollution, given that these minuscule particles can delve deep into the lungs, leading to inflammation, cell injury, and mutations that may instigate cancer. Lung cancer surgery can decrease lung cancer-related fatalities by facilitating early extraction of malignant tumors before they can advance or spread. For example, the Centers for Disease Control and Prevention, a US federal government agency, stated in June 2025 that lung cancer had caused 131,584 deaths in the United States in 2023, subsequent to 218,893 fresh cases reported in 2022. Consequently, the rise in lung cancer cases is fueling the development of the lung cancer surgery market.

How Is The Global Lung Cancer Surgery Market Categorized By Segments?

The lung cancer surgery market covered in this report is segmented –

1) By Type: Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Long-Term Trends Are Likely To Affect The Lung Cancer Surgery Market?

Key players in the lung cancer surgery market are prioritizing the creation of groundbreaking technologies such as robotic-assisted surgeries. Their objectives include increasing surgical accuracy, minimizing recovery periods, and boosting patient results. Robotic-assisted surgeries are minimally invasive operations executed using robot systems under the control of surgeons, offering improved precision, fewer complications, and better patient recovery outcomes. Johnson & Johnson MedTech, an American medical devices and technology corporation, disclosed in March 2025 its regulatory approval of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform provides an extended range and stability, enabling access to small, difficult-to-reach lung nodules, hence, improving early lung cancer detection. Its superior maneuverability coupled with the integration of imaging technologies lead to more precise biopsies while reducing patient discomfort. It is constructed to enhance procedural capabilities and simplify the workflow, providing greater clinical assurance and uniformity across many bronchoscopic procedures.

Which Firms Are Considered Leaders In The Lung Cancer Surgery Market Space?

Major companies operating in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

What Role Do Regional Policies And Investments Play In Lung Cancer Surgery Market Expansion?

North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model